2652 Stock Chart & Stats
HK$22.98
--
Market closed
HK$22.98
--
Day’s Range― - ―
52-Week RangeHK$14.82 - HK$48.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.76M
Market Cap
HK$6.44B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding302,223,570
10 Day Avg. Volume2,763,180
30 Day Avg. Volume2,763,180
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CF PharmTech. Inc. Class H News
2652 FAQ
What was CF PharmTech. Inc. Class H’s price range in the past 12 months?
CF PharmTech. Inc. Class H lowest stock price was HK$14.82 and its highest was HK$48.80 in the past 12 months.
What is CF PharmTech. Inc. Class H’s market cap?
CF PharmTech. Inc. Class H’s market cap is HK$6.44B.
When is CF PharmTech. Inc. Class H’s upcoming earnings report date?
CF PharmTech. Inc. Class H’s upcoming earnings report date is Aug 31, 2026 which is in 4 days.
How were CF PharmTech. Inc. Class H’s earnings last quarter?
Currently, no data Available
Is CF PharmTech. Inc. Class H overvalued?
According to Wall Street analysts CF PharmTech. Inc. Class H’s price is currently Overvalued.
Does CF PharmTech. Inc. Class H pay dividends?
CF PharmTech. Inc. Class H does not currently pay dividends.
What is CF PharmTech. Inc. Class H’s EPS estimate?
CF PharmTech. Inc. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CF PharmTech. Inc. Class H have?
CF PharmTech. Inc. Class H has 302,223,570 shares outstanding.
What happened to CF PharmTech. Inc. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CF PharmTech. Inc. Class H?
Currently, no hedge funds are holding shares in HK:2652
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CF PharmTech. Inc. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
CF PharmTech. Inc. Class H
CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name. The company also develops products for the treatment of respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and other respiratory diseases. In addition, it develops therapeutic products for respiratory and other diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes. Further, the company provides CDMO/CMO technical services. CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech, Inc. was founded in 2007 and is based in Suzhou, China.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
Tianda Pharmaceuticals Ltd.
―
Lee's Pharmaceutical Holdings Limited
―
Jacobson Pharma Corporation Limited
―
Sinco Pharmaceuticals Holdings Ltd.
―